The global dermatology devices market is expected to grow at a compound annual growth rate of 5.86% over the forecast period to reach a market size of US$32.162 billion in 2026 from US$21.592 billion in 2019.
The growing prevalence of skin problems like skin rash, acne, and mycosis along with the increasing awareness about aesthetic procedures are considered as the driving force for the growth of the market. Growing health care expenditure and increasing demand for non-invasive cosmetic correction procedures are also expected to fuel the growth of the dermatology devices market. However, a complication associated with dermatological treatments is considered as the restraining factor for the growth of the market.
Growing prevalence of skin diseases and problems.
Some of the most common types of skin conditions are acne, atopic dermatitis, hair loss, skin cancer, and other related conditions. According to the data given by the American Academy of Dermatology, acne has become the most common skin problem and condition in the United States, in the past few years. Around 50 million Americans are being affected by acne, per year. Moreover, the total treatment costs associated with the treatment amounted to more than US$1.2 billion in the United States. Major companies and organizations have been introducing novel and advanced solutions to treat this condition, for the past few years. Various studies have stated that laser and other light treatments are required to reduce acne. The United States Food and Drug Administration had already approved some types of visible light LED devices, such as red, blue, and blue+red devices, for home use. These trends are expected to have a positive impact on the market, in the coming years.
The United States is expected to have a major share.
The United States is expected to have a major share in the market, due to the increasing prevalence of skin diseases and conditions in the country. For instance, in the United States, around one in ten people usually develops atopic dermatitis, during their respective lifetime. Hair loss has also become one of the major concerns in the country. The most common cause of hair loss is baldness or hereditary thinning, which is also called androgenetic alopecia. According to the data given by the American Academy of Dermatology Association, hair loss conditions had affected an estimated number of 80 million Americans, with around 30 million women and 50 million men. Another skin condition such as Psoriasis has also become a major concern in the country. Around 7.5 million people have psoriasis in the United States. More than US$50 billion is spent in the treatment of psoriasis in the country, per year. These trends and numbers are expected to surge the adoption of novel and advanced dermatology devices in the country, during the forecast period.
The rising rate of skin cancer.
The market is expected to surge in the coming years, due to the increasing prevalence rate of skin cancer, globally. According to the data given by the American Institute for Cancer Research and World Cancer Research Fund, skin cancer has become the 19th most common cancer, globally. Around 300,000 novel cases of melanoma skin cancer were found in the year 2018 and 2019. Non-melanoma skin cancer has also become a major concern in both men and women. Over one million diagnoses were reported in the year 2019. Major companies and organizations have been making significant developments in the market, in the past few years. The development of novel and advanced solutions is also expected to play a crucial role in the overall market growth. For instance, the DermaSensor had been created to help overcome the major challenges, that are associated with a conventional skin cancer diagnosis. The novel device has been a handled objective skin cancer that utilizes and uses both light and pulses and spectroscopy to identify and find information about a skin lesion. These trends are expected to have a positive impact on the market, in the coming years.
The market is expected to grow at a significant rate in the coming years, due to the rise in the number of innovative, advanced, and new solutions. Major companies, R&D institutions, and organizations have been making a considerable impact in the market.
In June 2021, Aesthetics Biomedical, a topical skincare product development, and aesthetic device company announced that it had been given FDA clearance for their Vivace radiofrequency micro-needling device for its use at both 1MHz and 2MHz frequency. The novel device had been designed to treat different signs of aging, which includes skin laxity and wrinkles.
In June 2021, Eclipse, a major medical and aesthetic manufacturer, announced that it had been given FDA clearance of its latest and novel grade micro-needling device, known as the MicroPen EVO. The device would be available in aesthetic and dermatology practices in the United States.
|Market size value in 2019||US$21.592 billion|
|Market size value in 2026||US$32.162 billion|
|Growth Rate||CAGR of 5.86% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Application, End-Users, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Syneron Medical Ltd., Quanta Systems, Cynosure Inc., Alma Lasers Ltd., Lumenis Ltd., Cutera Inc., Genesis Biosystems Inc., 3Gen Inc., Avita Medical Ltd., Aesthetics Biomedical|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What is the size of global dermatology devices market?
A1. Dermatology Devices Market was valued at US$21.592 billion in 2019.
Q2. What will be the dermatology devices market size by 2026?
A2. The global dermatology devices market is expected to reach a total market size of US$32.162 billion by 2026.
Q3. What are the growth prospects for the dermatology devices market?
A3. The dermatology devices market is expected to grow at a CAGR of 5.86% during the forecast period.
Q4. What factors are anticipated to drive the dermatology devices market growth?
A4. The growing prevalence of skin problems like skin rash, acne, and mycosis along with the increasing awareness about aesthetic procedures are considered as the driving force for the growth of the dermatology devices market.
Q5. Which region holds the largest market share in the dermatology devices market?
A5. The United States is expected to have a major share in the dermatology devices market, due to the increasing prevalence of skin diseases and conditions in the country.
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Dermatology Devices Market Analysis, By Application
5.2. Skin Cancer Diagnosis
5.3. Hair Removal
5.4. Wrinkle Removal
5.5. Skin Rejuvenation
5.6. Acne & Psoriasis removal
6. Global Dermatology Devices Market Analysis, By End-Users
6.3. Specialty Dermatology Clinics
7. Global Dermatology Devices Market Analysis, By Geography
7.2. North America
7.2.1. United States
7.3. South America
7.5. Middle East and Africa
7.6. Asia Pacific
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Syneron Medical Ltd.
9.2. Quanta Systems
9.3. Cynosure Inc.
9.4. Alma Lasers Ltd.
9.5. Lumenis Ltd.
9.6. Cutera Inc.
9.7. Genesis Biosystems Inc.
9.8. 3Gen Inc.
9.9. Avita Medical Ltd.
9.10. Aesthetics Biomedical
Syneron Medical Ltd.
Alma Lasers Ltd.
Genesis Biosystems Inc.
Avita Medical Ltd.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.